Skip to main content
OpenTrials
Recruiting

NCT Number: NCT05236348

Performance of the Aktiia Optical Blood Pressure Monitoring Device Against Double Auscultation

This study with N = 225 participants (1 cohort of a minimum of 85 and maximum of 140 participants, and an additional cohort with 85 participants) over 9 visits has been designed to assess the accuracy of Aktiia.product-us systolic and diastolic blood pressure measurements against double-auscultation reference measurements. In order to induce blood pressure changes and to simulate ambulatory scenarios, the study participants will be asked to perform a set of activities, involving body position changes and physical exercises. Additionally, this study will compare the heart rate measured by Aktiia.product-us against the reference readings provided by a finger pulse oximeter (as per ISO80601-2-61). The reliability of the auscultation readings will be controlled with simultaneous volume-clamp measurements.

Recruiting

Interested in participating?

Request Info

Key information

Age range

21 year–85 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

University of Lausanne Hospitals

Lausanne, 1011, Switzerland

Location status: Recruiting

Location contact

Grégoire Wuerzner, MD

CONTACT

[email protected]

+41213141131

About this study

According to the World Health Organization, by 2025 hypertension will affect 1.5 billion adults worldwide. Half of the adult population suffering from hypertension is currently not diagnosed and half of the treated population is not at the defined target of BP.

Widespread use of out-of-office Blood Pressure measurement is one of the proposed strategies to fight against hypertension worldwide.

Aktiia S.A. has developed an intermittent automated non-invasive cuffless blood pressure monitor, determining the values of the systolic blood pressure, the diastolic blood pressure and the heart rate. This miniature device is comfortably positioned with a bracelet on a user's wrist.

The goal of this study is to establish a reasonable assurance of safety and effectiveness with Aktiia OBPM system for monitoring blood pressure in home use.

In particular, the study will collect data from subjects by means of the device under test and collect data from subjects by means of double-auscultation, pulse oximetry and volume-clamp BP reading while subjects wear the devices at different body positions and induce Blood Pressure changes, during eight visits that will be held over the span of seven days, and generate performance reports.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adult subjects (aged between 21 and 85 years old)
  • Subjects can read and speak French
  • Subjects can perform simple physical exercises
  • Subjects agreeing to attend the totality of 9 visits
  • Subjects that have signed the informed consent form

Exclusion criteria

  • Clinical staff collaborating with study PI
  • Subjects with tachycardia (heart rate at rest > 120bpm)
  • Subjects with atrial fibrillation
  • Subjects with diabetes
  • Subjects with renal dysfunctions
  • Subjects with hyper-/hypothyroidism
  • Subjects with pheochromocytoma
  • Subjects with Raynaud's disease
  • Subjects with trembling and shivering
  • Subjects with interarm systolic difference > 15 mmHg
  • Subjects with interarm diastolic difference > 10 mmHg
  • Subjects with arm paralysis
  • Women in known pregnancy (for ARM 1 only)
  • Subjects with an arteriovenous fistula
  • Subjects with arm amputations
  • Subjects with the upper arm circumference < 22cm or > 42 cm
  • Subjects with the wrist circumference > 21 cm
  • Subjects with the exfoliative skin diseases
  • Subjects with lymphoedema

Treatment and study plan

Aktiia.product-us

Device

The study will collect data from subjects by means of the device under test and collect data from subjects by means of double-auscultation, pulse oximetry and volume-clamp BP reading while subjects wear the devices at different body positions and induce BP changes, during eight visits that will be held over the span of seven days, and generate performance reports.

Other names: Aktiia bracelet, Aktiia product, Aktiia.product

Primary outcomes

  1. Blood pressure mean value of differences

    Time frame: 1 week

    The mean value of the differences between Aktiia.product-us and double auscultation blood pressure measurements.

  2. Blood pressure standard deviation of differences

    Time frame: 1 week

    The standard deviation of the differences between Aktiia.product-us and double auscultation blood pressure measurements.

Secondary outcomes

  1. Heart rate root-mean-square error

    Time frame: 1 week

    The root-mean-square difference between the Aktiia.product-us heart rate determinations and the reference method.

Study contacts

Contact information is provided by the study sponsor or research team.

Josep Sola, PhD

CONTACT

[email protected]

+41797689800

Sponsors and collaborators

Lead sponsor

Aktiia SA

Industry

Registry information

Official study title

Single-center Prospective Clinical Trial to Validate the Performance of the Aktiia Optical Blood Pressure Monitoring (OBPM) Device at the Wrist Against Double Auscultation

Important dates

Study start
2022
Primary completion
2025
Study completion
2025
First posted
Feb 11, 2022
Registry last updated
Aug 19, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.